In spite of the recently published Cochrane Research meta-analysis, which examined 7 previously published studies on the value of mammographic screening, the benefit of mammography is still very much up for discussion. This last-day ASCO presentation assembled a group of 5 men (4 of them physicians, the other a statistician), 4 of whom presented extensive but conflicting interpretations of the same data sets in order to justify their opinion as to whether women should undergo routine mammography. In contrast, 5 women — none of them physicians but all connected with national breast cancer groups, foundations, and causes — were given a few minutes each to state their own opinions, none of which were supported by scientific data or presented in a scientific format. Why ASCO chose to stack the scientific portion of this presentation with male MDs/PhDs while the women were relegated to discuss their personal but unscientific thoughts regarding this critical issue is unclear. A far different discussion might have ensued had well-known female breast cancer physicians been invited to participate.
האם המהפכה הטיפולית בהשמנת יתר תפרוץ את חומת הכלכלה? פרופ' רז ופרופ' שטרן
לפניכם הרצאה ודיון שהתקיים בין פרופ’ איתמר רז ופרופ’ נפתלי שטרן בנושא השפעות החידושים הטיפוליים בתחום ההשמנה.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!